Skip to main content
. 2021 Jan 20;11(1):2045894020981350. doi: 10.1177/2045894020981350

Fig. 1.

Fig. 1.

Effects of add-on sequential therapy with inhaled iloprost to a PDE5i and ERA, for at least 12 weeks. (a) Hemodynamic and BNP data. (b) Functional class and improvement in ESC/ERS risk stratification data.

RAP: right atrial pressure; PAP: pulmonary arterial pressure; Pwedge: Wedge pressure; PVR: pulmonary vascular resistance; BNP: brain natriuretic peptide.